Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination | Zendy

Miia Virta | Zendy; Anu Soininen | Zendy; Dhaval M. Patel | Zendy; Céline Petit | Zendy; Cynthia Tabar | Zendy; Olga Lyabis | Zendy

Open Access

Persistence of Hepatitis B Immune Memory Until 6 Years of Age Following Hexavalent DTaP-IPV-HB-PRP~T Vaccination in a 3-, 5- and 11- to 12-month Schedule and Response to a Subsequent Hepatitis B Challenge Vaccination

Author(s) -

Miia Virta,

Anu Soininen,

Dhaval M. Patel,

Céline Petit,

Cynthia Tabar,

Olga Lyabis

Publication year - 2020

Publication title -

the pediatric infectious disease journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.028

H-Index - 140

eISSN - 1532-0987

pISSN - 0891-3668

DOI - 10.1097/inf.0000000000002954

Subject(s) - persistence (discontinuity) , medicine , immunology , hepatitis b , vaccination , immunological memory , antibody , immune system , virology , immunity , geotechnical engineering , engineering

Anti-hepatitis B (HBs) antibody persistence and hepatitis B challenge were evaluated at 6 years of age following vaccination of fully liquid DTaP-IPV-HB-PRP~T or reconstituted DTaP-IPV-HB//PRP~T at 3, 5, 11-12 months of age. At 6 years, 53.8% and 73.5% had seroprotective anti-HBs antibodies (≥10 mIU/mL), increasing to 96.7% and 95.9% postchallenge, confirming a strong anamnestic response in primed vaccinees.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research